Arzneiverordnungs-Report 2012 2012
DOI: 10.1007/978-3-642-29242-2_18
|View full text |Cite
|
Sign up to set email alerts
|

Betarezeptorenblocker

Björn Lemmer
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2013
2013
2013
2013

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…46,47 Many studies have shown that cardiovascular related events, such as myocardial infarction and stroke, often occur in the early morning due to circadian changes regulating blood pressure, heart rate, vasodilating hormones, etc. 47,48 Dihydropyridine calcium channel blockers, such as Norvasc, have been shown that time of day dosing, particularly evening, is the most advantageous for efficacy of the treatment and normalizing changes in blood pressure rhythms to reduce early morning cardiac events. 47,48 ACE inhibitors, AT-receptor blockers, diuretics, and other antihypertensives have also been studied to determine circadian-based time of day dosing for the most effective treatment.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…46,47 Many studies have shown that cardiovascular related events, such as myocardial infarction and stroke, often occur in the early morning due to circadian changes regulating blood pressure, heart rate, vasodilating hormones, etc. 47,48 Dihydropyridine calcium channel blockers, such as Norvasc, have been shown that time of day dosing, particularly evening, is the most advantageous for efficacy of the treatment and normalizing changes in blood pressure rhythms to reduce early morning cardiac events. 47,48 ACE inhibitors, AT-receptor blockers, diuretics, and other antihypertensives have also been studied to determine circadian-based time of day dosing for the most effective treatment.…”
mentioning
confidence: 99%
“…47,48 Dihydropyridine calcium channel blockers, such as Norvasc, have been shown that time of day dosing, particularly evening, is the most advantageous for efficacy of the treatment and normalizing changes in blood pressure rhythms to reduce early morning cardiac events. 47,48 ACE inhibitors, AT-receptor blockers, diuretics, and other antihypertensives have also been studied to determine circadian-based time of day dosing for the most effective treatment.…”
mentioning
confidence: 99%